Xcout Intel
Pulmair Medical, Inc.
Pulmair Medical, Inc. is a biotechnology services provider founded in 2018 and headquartered in San Diego, California. The company focuses on specialized medical research and biopharmaceutical development.
Subscribe to see Pulmair Medical, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Pulmair Medical, Inc. at a glance
Pulmair Medical, Inc. is a medical devices company headquartered in United States. Its most recent funding round raised $7.5M in July 2019. Xcout tracks 8 named people at Pulmair Medical, Inc., including Marcelo G. Lima (PRESIDENT & CEO).
Pulmair Medical, Inc. leadership
- Marcelo G. LimaPRESIDENT & CEO
- Herbert RadischVP OF ENGINEERING & CTO
- Tracey KrugerVP BUSINESS DEVELOPMENT & CLINICAL OPERATIONS
- Paul MasonREGULATORY AFFAIRS
- Marcelo G. LimaCHAIRMAN
- Erica SnyderDIRECTOR
2 more named people on record for Pulmair Medical, Inc., with roles, board committees and tenure — see the full roster →
Pulmair Medical, Inc. funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $7.5M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Pulmair Medical, Inc. competitors
A few of Pulmair Medical, Inc.'s closest competitors — see the full list of competitors and alternatives →
Beyond Air, Inc. functions as a specialized entity involved in both the development of medical devices and biopharmaceutical solutions. A central part of its operations is the LungFit platform, an innovative system that generates and delivers nitric oxide. Within this platform, LungFit PH is currently available, used to address persistent pulmonary hypertension in infants. Furthermore, the company is advancing LungFit PRO, a product intended for various viral lung ailments like community-acquired viral pneumonia (including COVID-19) and bronchiolitis in hospital settings. It is also creating LungFit GO, which aims to treat nontuberculous mycobacteria infections. The organization adopted its current name, Beyond Air, Inc., in June 2019, having previously been known as AIT Therapeutics, Inc. Its headquarters are situated in Garden City, New York.
Get Pulmair Medical, Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Pulmair Medical, Inc. in Xcout Intel
- 8 named people with titles, LinkedIn and board committees
- 1 funding round with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access